-
1مؤتمر
المؤلفون: McDermott, David F., Lee, Jae-Lyun, Bjarnason, Georg A., Larkin, James M. G., Gafanov, Rustem Airatovich, Kochenderfer, Mark D., Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S., Gordoa, Teresa Alonso, Cho, Daniel C., Geertsen, Poul F., Duran, Miguel Angel Climent, Simone, Christopher Di, Du, Xiaoqi, Perini, Rodolfo F., Rodriguez-Lopez, Karla, Atkins, Michael B.
المصدر: McDermott , D F , Lee , J-L , Bjarnason , G A , Larkin , J M G , Gafanov , R A , Kochenderfer , M D , Jensen , N V , Donskov , F , Malik , J , Poprach , A , Tykodi , S S , Gordoa , T A , Cho , D C , Geertsen , P F , Duran , M A C , Simone , C D , Du , X , Perini , R F , Rodriguez-Lopez , K & Atkins , M B 2020 , ' First-line ....
العلاقة: https://portal.findresearcher.sdu.dk/da/publications/c5030676-a743-4298-97b4-654c3752ce72Test
الإتاحة: https://doi.org/10.1200/JCO.2020.38.15_suppl.5069Test
https://portal.findresearcher.sdu.dk/da/publications/c5030676-a743-4298-97b4-654c3752ce72Test -
2دورية أكاديمية
المؤلفون: McDermott, David F., Lee, Jae Lyun, Bjarnason, Georg A., Larkin, James M.G., Gafanov, Rustem A., Kochenderfer, Mark D., Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S., Alonso-Gordoa, Teresa, Cho, Daniel C., Geertsen, Poul F., Climent Duran, Miguel Angel, DiSimone, Christopher, Silverman, Rachel Kloss, Perini, Rodolfo F., Schloss, Charles, Atkins, Michael B.
المصدر: McDermott , D F , Lee , J L , Bjarnason , G A , Larkin , J M G , Gafanov , R A , Kochenderfer , M D , Jensen , N V , Donskov , F , Malik , J , Poprach , A , Tykodi , S S , Alonso-Gordoa , T , Cho , D C , Geertsen , P F , Climent Duran , M A , DiSimone , C , Silverman , R K , Perini , R F , Schloss , C & Atkins , M B 2021 , ' Open-Label, ....
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodies, Monoclonal, Humanized/therapeutic use, Antineoplastic Agents, Immunological/therapeutic use, Carcinoma, Renal Cell/drug therapy, Female, Follow-Up Studies, Humans, Kidney Neoplasms/drug therapy, Male, Middle Aged, Non-Randomized Controlled Trials as Topic, Prognosis, Survival Rate
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1200/JCO.20.02363Test
https://pure.au.dk/portal/en/publications/bae5aee9-7f1b-4552-855b-cfdb62d318f9Test
https://pure.au.dk/ws/files/274416924/jco.20.02363.pdfTest
http://www.scopus.com/inward/record.url?scp=85103228704&partnerID=8YFLogxKTest -
3دورية أكاديمية
المؤلفون: Vogelzang, Nicholas J, Olsen, Mark R, McFarlane, Joshua J, Arrowsmith, Edward, Bauer, Todd M, Jain, Rohit K, Somer, Bradley, Lam, Elaine T, Kochenderfer, Mark D, Molina, Ana, Doshi, Gurjyot, Lingerfelt, Brian, Hauke, Ralph J, Gunuganti, Vijay, Schnadig, Ian, Van Veldhuizen, Peter, Fleming, Mark, Galamaga, Robert, Gupta, Mukul, Hool, Hugo, Hutson, Thomas, Zhang, Joshua, McHenry, M Brent, Johansen, Jennifer L, Tykodi, Scott S
المصدر: ENT and Skull Base Surgery
مصطلحات موضوعية: Chromophobe renal cell carcinoma, Immunotherapy, Papillary renal cell carcinoma, Renal collecting duct carcinoma, Sarcomatoid renal cell carcinoma, Carcinoma, Renal Cell (drug therapy), Cohort Studies, Humans, Kidney Neoplasms (drug therapy), Nivolumab (adverse effects), Progression-Free Survival
العلاقة: https://scholar.barrowneuro.org/ent-and-skull-base-surgery/19Test; https://doi.org/10.1016/j.clgc.2020.05.006Test
الإتاحة: https://doi.org/10.1016/j.clgc.2020.05.006Test
https://scholar.barrowneuro.org/ent-and-skull-base-surgery/19Test -
4دورية أكاديمية
المؤلفون: McFarlane, Joshua J., Kochenderfer, Mark D., Olsen, Mark R., Bauer, Todd M., Molina, Ana, Hauke, Ralph J., Reeves, James A., Babu, Sunil, Van Veldhuizen, Peter, Somer, Bradley, Gunuganti, Vijay, Schnadig, Ian, George, Saby, Page, Ray D., Arrowsmith, Edward, Jain, Rohit K., Zhang, Joshua, McHenry, M. Brent, Johansen, Jennifer L., Vogelzang, Nicholas J.
المساهمون: Bristol-Myers Squibb Company, Daiichi-Sankyo, Medpacto, Incyte, Mirati Therapeutics, MedImmune, AbbVie, AstraZeneca, MabVax, Stemline Therapeutics, Merck, Lilly, GlaxoSmithKline, Novartis, Genentech, Deciphera, Merrimack, Immunogen, Millennium, Phosplatin Therapeutics, Calithera Biosciences, Kolltan Pharmaceuticals, Principa Biopharma, Peloton Pharmaceuticals, Immunocore, Roche, Aileron Therapeutics, Amgen, Onyx, Sanofi, Boehringer Ingelheim, Astellas Pharma, Five Prime Therapeutics, Jacobio, Top Alliance BioScience, Janssen, Clovis Oncology, Takeda, Karyopharm Therapeutics, Foundation Medicine, ARMO Biosciences, Pfizer, Loxo, Sarah Cannon Research Institute, Eli Lilly, Tesaro, TG Therapeutics, Celgene, BMS, Boston Biomedical Inc, Novocure, Guardant Health, Acerta Pharma, Rhizen Pharmaceuticals, Takeda Pharmaceuticals, Onconova Therapeutics, CTI Biopharma, Bayer, Corvus, Acceleron, Agensys, Eisai
المصدر: Clinical Genitourinary Cancer ; volume 18, issue 6, page 469-476.e4 ; ISSN 1558-7673
الإتاحة: https://doi.org/10.1016/j.clgc.2020.06.002Test
https://api.elsevier.com/content/article/PII:S1558767320301415?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S1558767320301415?httpAccept=text/plainTest -
5دورية أكاديمية
المؤلفون: McDermott, David F, Lee, Jae-Lyun, Bjarnason, Georg A, Larkin, James M G, Gafanov, Rustem A, Kochenderfer, Mark D, Jensen, Niels Viggo, Donskov, Frede, Malik, Jahangeer, Poprach, Alexandr, Tykodi, Scott S, Alonso-Gordoa, Teresa, Cho, Daniel C, Geertsen, Poul F, Climent Duran, Miguel Angel, DiSimone, Christopher, Silverman, Rachel Kloss, Perini, Rodolfo F, Schloss, Charles, Atkins, Michael B
المصدر: Journal of Clinical Oncology; 3/20/2021, Vol. 39 Issue 9, p1020-1028, 9p
-
6دورية
المؤلفون: Vogelzang, Nicholas J., Olsen, Mark R., McFarlane, Joshua J., Arrowsmith, Edward, Bauer, Todd M., Jain, Rohit K., Somer, Bradley, Lam, Elaine T., Kochenderfer, Mark D., Molina, Ana, Doshi, Gurjyot, Lingerfelt, Brian, Hauke, Ralph J., Gunuganti, Vijay, Schnadig, Ian, Van Veldhuizen, Peter, Fleming, Mark, Galamaga, Robert, Gupta, Mukul, Hool, Hugo, Hutson, Thomas, Zhang, Joshua, McHenry, M. Brent, Johansen, Jennifer L., Tykodi, Scott S.
المصدر: Clinical Genitourinary Cancer; December 2020, Vol. 18 Issue: 6 p461-468.e3